RedHill Biopharma Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
RedHill Biopharma Ltd. Earnings Date And Information
RedHill Biopharma Ltd. last posted its earnings results on Thursday, August 29th, 2024. The company reported $-200 earnings per share for the quarter, missing analysts' consensus estimates of $-30 by $170. The company had revenue of 1.80 M for the quarter and had revenue of 6.51 M for the year. RedHill Biopharma Ltd. has generated $4 earnings per share over the last year ($3.68 diluted earnings per share) and currently has a price-to-earnings ratio of 2.19. RedHill Biopharma Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 26th, 2024 based on prior year's report dates.
RedHill Biopharma Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/17/2023 | Q2 2023 | $0.19 | $23.48 M | $1.80 M | ||
| 08/17/2023 | Q1 2023 | $20.44 | $3.60 M | |||
| 04/28/2023 | Q4 2022 | $1.07 | $12.80 M | |||
| 09/29/2022 | Q3 2022 | -$40.29 | $18.50 M | $17.55 M | ||
| 11/07/2022 | Q2 2022 | -$10.04 | $21.50 M | $18.35 M | ||
| 03/17/2022 | Q1 2022 | -$400.00 | -$13.36 | 386.64 | $18.24 M | |
| 03/17/2022 | Q4 2021 | -$400.00 | -$19.65 | 380.35 | $22.07 M | |
| 09/29/2021 | Q3 2021 | -$18.28 | $24.51 M | $21.61 M | ||
| 05/27/2021 | Q2 2021 | -$460.00 | -$24.95 | 435.05 | $24.29 M | $21.50 M |
| 05/27/2021 | Q1 2021 | -$460.00 | -$21.29 | 438.71 | $20.58 M | |
| 03/18/2021 | Q4 2020 | -$450.00 | -$25.69 | 424.31 | $21.46 M | |
| 09/29/2020 | Q3 2020 | -$19.99 | $25.36 M | $20.94 M | ||
| 06/29/2020 | Q2 2020 | -$17.95 | $22.99 M | $20.90 M | ||
| 03/04/2020 | Q1 2020 | -$320.00 | -$19.46 | 300.54 | $1.06 M | |
| 11/19/2019 | Q4 2019 | -$390.00 | -$13.89 | 376.11 | $1.59 M | |
| 11/19/2019 | Q3 2019 | -$390.00 | -$13.87 | 376.13 | $1.79 M | $1.40 M |
| 05/07/2019 | Q2 2019 | -$15.38 | $2.16 M | $1.56 M | ||
| 02/26/2019 | Q1 2019 | -$390.00 | -$13.92 | 376.08 | $1.74 M | |
| 11/13/2018 | Q4 2018 | -$400.00 | -$11.68 | 388.32 | $1.36 M | |
| 08/30/2018 | Q3 2018 | -$470.00 | -$17.17 | 452.83 | $2.21 M |
RedHill Biopharma Ltd. Earnings: Frequently Asked Questions
-
When is RedHill Biopharma Ltd.'s earnings date?
RedHill Biopharma Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 26th, 2024 based off last year's report dates.
-
How can I listen to RedHill Biopharma Ltd.'s earnings conference call?
The conference call for RedHill Biopharma Ltd.'s latest earnings report can be listened to online.
-
How can I read RedHill Biopharma Ltd.'s conference call transcript?
The conference call transcript for RedHill Biopharma Ltd.'s latest earnings report can be read online.
-
How much revenue does RedHill Biopharma Ltd. generate each year?
RedHill Biopharma Ltd. (:RDHL) has a recorded annual revenue of $6.51 M.
-
How much profit does RedHill Biopharma Ltd. generate each year?
RedHill Biopharma Ltd. (:RDHL) has a recorded net income of $6.51 M. RedHill Biopharma Ltd. has generated $3.68 earnings per share over the last four quarters.
-
What is RedHill Biopharma Ltd.'s price-to-earnings ratio?
RedHill Biopharma Ltd. (:RDHL) has a price-to-earnings ratio of 2.19 and price/earnings-to-growth ratio is 0.06.
